Jannini EA, Lenzi A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J Urol. 2005 Jun. 23(2):68-75. [QxMD MEDLINE Link].
McMahon CG. Management of ejaculatory dysfunction. Intern Med J. 2014 Feb. 44 (2):124-31. [QxMD MEDLINE Link].
Stadler T, Bader M, Uckert S, Staehler M, Becker A, Stief CG. Adverse effects of drug therapies on male and female sexual function. World J Urol. 2006 Dec. 24(6):623-9. [QxMD MEDLINE Link].
Alwaal A, Breyer BN, Lue TF. Normal male sexual function: emphasis on orgasm and ejaculation. Fertil Steril. 2015 Nov. 104 (5):1051-60. [QxMD MEDLINE Link].
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2022.
Meisel RL, Sachs BD. The physiology of male sexual behavior. In: Knobil E, Neill JD, editors. The Physiology of Reproduction. 3-105. 3rd. New York: Raven Press; 2005.
Hull EM, Du J, Lorrain DS, Matuszewich L. Extracellular dopamine in the medial preoptic area: implications for sexual motivation and hormonal control of copulation. J Neurosci. 1995 Nov. 15(11):7465-71. [QxMD MEDLINE Link].
Bitran D, Hull EM. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev. 1987 Winter. 11(4):365-89. [QxMD MEDLINE Link].
Giuliano F, Clément P. Serotonin and premature ejaculation: from physiology to patient management. Eur Urol. 2006 Sep. 50(3):454-66. [QxMD MEDLINE Link].
Cantor JM, Binik YM, Pfaus JG. Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin. Psychopharmacology (Berl). 1999 Jun. 144(4):355-62. [QxMD MEDLINE Link].
Peeters M, Giuliano F. Central neurophysiology and dopaminergic control of ejaculation. Neurosci Biobehav Rev. 2008. 32 (3):438-53. [QxMD MEDLINE Link].
Wolters JP, Hellstrom WJ. Current concepts in ejaculatory dysfunction. Rev Urol. 2006. 8 Suppl 4:S18-25. [QxMD MEDLINE Link]. [Full Text].
Krüger T, Exton MS, Pawlak C, von zur Mühlen A, Hartmann U, Schedlowski M. Neuroendocrine and cardiovascular response to sexual arousal and orgasm in men. Psychoneuroendocrinology. 1998 May. 23(4):401-11. [QxMD MEDLINE Link].
Krüger TH, Haake P, Chereath D, Knapp W, Janssen OE, Exton MS, et al. Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J Endocrinol. 2003 Apr. 177(1):57-64. [QxMD MEDLINE Link].
Kaplan HS. Post-ejaculatory pain syndrome. J Sex Marital Ther. 1993 Summer. 19(2):91-103. [QxMD MEDLINE Link].
Waldinger MD, Schweitzer DH. Postorgasmic illness syndrome: two cases. J Sex Marital Ther. 2002 May-Jun. 28(3):251-5. [QxMD MEDLINE Link].
Paduch DA, Polzer P, Morgentaler A, Althof S, Donatucci C, Ni X, et al. Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other Than Premature Ejaculation: A Prospective, Observational Study. J Sex Med. 2015 Dec. 12 (12):2276-86. [QxMD MEDLINE Link].
Gingell C, Nicolosi A, Glasser DB, Brock G, Buvat J. Sexual behaviors and functioning in mature men: results of an international survey. 2nd World Congress of Mens Health. 25-27. Vienna; October 2002.
Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav. 2001 Apr. 30(2):177-219. [QxMD MEDLINE Link]. [Full Text].
Dunsmuir WD, Feneley M, Corry DA, Bryan J, Kirby RS. The day-to-day variation (test-retest reliability) of residual urine measurement. Br J Urol. 1996 Feb. 77(2):192-3. [QxMD MEDLINE Link].
Johnson SD, Phelps DL, Cottler LB. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch Sex Behav. 2004 Feb. 33(1):55-63. [QxMD MEDLINE Link].
Komisaruk BR , Beyer-Flores C, Whipple B. Recreational Stimulant Drugs and Orgasm. In: The Science of Orgasm. Johns Hopkins University: 2006:146-148.
Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br J Psychiatry. 1987 Jul. 151:107-12. [QxMD MEDLINE Link].
Merino MJ, Gonzalez P,Muniz J, Bobes J. Sexual dysfunction in depressed patients undergoing treatment with antidepressants. International Journal of Psychiatry in Clinical Practice. 2000;4:311-317.
Raja M. Risperidone-induced absence of ejaculation. Int Clin Psychopharmacol. 1999 Sep. 14(5):317-9. [QxMD MEDLINE Link].
Sun C, Lay C, Broner S, Silberstein S, Tepper S, Newman L. Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients. Headache. 2006 Oct. 46(9):1450-3. [QxMD MEDLINE Link].
Abdel-Hamid IA, Saleh el-S. Primary lifelong delayed ejaculation: characteristics and response to bupropion. J Sex Med. 2011 Jun. 8(6):1772-9. [QxMD MEDLINE Link].
Salerian AJ, Deibler WE, Vittone BJ, Geyer SP, Drell L, Mirmirani N, et al. Sildenafil for psychotropic-induced sexual dysfunction in 31 women and 61 men. J Sex Marital Ther. 2000 Apr-Jun. 26(2):133-40. [QxMD MEDLINE Link].
Aizenberg D, Shiloh R, Zemishlany Z, Weizman A. Low-dose imipramine for thioridazine-induced male orgasmic disorder. J Sex Marital Ther. 1996 Fall. 22(3):225-9. [QxMD MEDLINE Link].
Althof SE. Psychological interventions for delayed ejaculation/orgasm. Int J Impot Res. 2012 Jul-Aug. 24(4):131-6. [QxMD MEDLINE Link].
Buvat J, Jouannet P, eds. L’ejaculation et ses pertubations. 1984:79-83.
Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010 Apr. 7(4 Pt 2):1668-86. [QxMD MEDLINE Link].
Segraves RT. Considerations for a better definition of male orgasmic disorder in DSM V. J Sex Med. 2010 Feb. 7(2 Pt 1):690-5. [QxMD MEDLINE Link].
Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav. 1990 Aug. 19(4):389-408. [QxMD MEDLINE Link].
Robinson DS, Kajdasz DK, Gallipoli S, Whalen H, Wamil A, Reed CR. A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder. J Clin Psychopharmacol. 2011 Oct. 31 (5):643-6. [QxMD MEDLINE Link].
